Kessler Topaz Meltzer & Check, LLP Reminds PACS Shareholders of Deadline in Securities Fraud Class Action Lawsuit Filed Against PACS Group, Inc.

Core Viewpoint - A securities class action lawsuit has been filed against PACS Group, Inc. for allegedly making materially false and misleading statements regarding its business operations and financial performance during its IPO and subsequent period [1][2]. Summary by Sections Lawsuit Details - The lawsuit is on behalf of investors who purchased PACS common stock during its IPO on April 11, 2024, and securities between April 11, 2024, and November 5, 2024 [1]. - The lead plaintiff deadline for the lawsuit is set for January 13, 2025 [1]. Allegations Against PACS - The complaint alleges that PACS engaged in fraudulent activities, including: 1. Submitting false Medicare claims that accounted for over 100% of PACS' operating and net income from 2020 to 2023 [2]. 2. Billing for unnecessary respiratory and sensory integration therapies to Medicare [2]. 3. Falsifying documentation related to licensure and staffing [2]. - These actions led to materially misleading statements about the company's business and prospects [2]. Investor Information - Kessler Topaz Meltzer & Check, LLP encourages PACS investors who have experienced significant losses to contact the firm for more information [3].